Need Help?
14 May 2025
Journal of Clinical Medicine | Highly Cited Papers and Hot Topic Special Issues on Inflammatory Bowel Disease
Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an open access journal that covers all topics related to clinical and pre-clinical practices. In this issue, we are delighted to share some highly cited papers on inflammatory bowel disease and recommend open Special Issues for you to submit your recent research to.
1. “Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics”
by Tina Deyhim, Adam S. Cheifetz and Konstantinos Papamichael
J. Clin. Med. 2023, 12(22), 7132; https://doi.org/10.3390/jcm12227132
Full text available online: https://www.mdpi.com/2077-0383/12/22/7132
2. “The Optimal Management of Inflammatory Bowel Disease in Patients with Cancer”
by Panu Wetwittayakhlang, Paraskevi Tselekouni, Reem Al-Jabri, Talat Bessissow and Peter L. Lakatos
J. Clin. Med. 2023, 12(6), 2432; https://doi.org/10.3390/jcm12062432
Full text available online: https://www.mdpi.com/2077-0383/12/6/2432
3. “Systematic Review and Meta-Analysis of Observational Studies on the Effectiveness and Safety of Ustekinumab among Patients with Inflammatory Bowel Disease in Eastern and Western Countries”
by He Zhou, Fang Wang, Jian Wan, Song Su, Yanting Shi, Xiaofei Li, Tong Wu and Jie Liang
J. Clin. Med. 2023, 12(5), 1894; https://doi.org/10.3390/jcm12051894
Full text available online: https://www.mdpi.com/2077-0383/12/5/1894
4. “Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977–2020”
by Panu Wetwittayakhlang, Lorant Gonczi, Petra A. Golovics, Zsuzsanna Kurti, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Laszlo Lakatos and Peter L. Lakatos
J. Clin. Med. 2023, 12(8), 3026; https://doi.org/10.3390/jcm12083026
Full text available online: https://www.mdpi.com/2077-0383/12/8/3026
5. “Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels”
by Eva Hüttemann, Anna Muzalyova, Katharina Gröhl, Sandra Nagl, Carola Fleischmann, Alanna Ebigbo, Johanna Classen, Julia Wanzl, Friederike Prinz, Patrick Mayr et al.
J. Clin. Med. 2024, 13(1), 140; https://doi.org/10.3390/jcm13010140
Full text available online: https://www.mdpi.com/2077-0383/13/1/140
6. “The Interaction between Stress and Inflammatory Bowel Disease in Pediatric and Adult Patients”
by Oana Belei, Diana-Georgiana Basaca, Laura Olariu, Manuela Pantea, Daiana Bozgan, Anda Nanu, Iuliana Sîrbu, Otilia Mărginean and Ileana Enătescu
J. Clin. Med. 2024, 13(5), 1361; https://doi.org/10.3390/jcm13051361
Full text available online: https://www.mdpi.com/2077-0383/13/5/1361
7. “Crohn’s Disease-Associated and Cryptoglandular Fistulas: Differences and Similarities”
by Zhou Zhou, Laura F. Ouboter, Koen C. M. J. Peeters, Lukas J. A. C. Hawinkels, Fabian Holman, Maria F. Pascutti, Marieke C. Barnhoorn and Andrea E. van der Meulen-de Jong
J. Clin. Med. 2023, 12(2), 466; https://doi.org/10.3390/jcm12020466
Full text available online: https://www.mdpi.com/2077-0383/12/2/466
8. “Considering Histologic Remission in Ulcerative Colitis as a Long-Term Target”
by Christopher Pavel, Mircea Mihai Diculescu, Alex-Emilian Stepan, Gabriel Constantinescu, Vasile Sandru, Cristian George Ţieranu, Luiza Tomescu, Alexandru Constantinescu, Cristina Patoni, Oana-Mihaela Plotogea et al.
J. Clin. Med. 2024, 13(1), 289; https://doi.org/10.3390/jcm13010289
Full text available online: https://www.mdpi.com/2077-0383/13/1/289
|
Special Issues: |
|
|
“New Directions for Treatment and Assessment of Ulcerative Colitis” |
“Current Progress in Inflammatory Bowel Disease (IBD)” |
|
|
|

